Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

China Drugmakers Rise in Shenzhen on Report of Support Plan

Aug. 10 (Bloomberg) -- China’s drugmakers rose in Shenzhen trading after a newspaper reported that the nation may spend more than 10 billion yuan ($1.5 billion) to support biotechnology and pharmaceutical industries.

Guilin Layn Natural Ingredients Corp. jumped 6.5 percent to 30 yuan at the 11:30 a.m. local-time break. Anhui Anke Biotechnology (Group) Co. rose 4.7 percent to 24 yuan and Shenzhen Neptunus Bioengineering Co. added 2.4 percent to 12.32 yuan.

The 21st Century Business Herald reported today that the plan, aiming to support development of new drugs, has been submitted to the National Development and Reform Commission and may be announced as soon as the end of this month.

Link to Company News:{000078 CH <Equity> CN <GO>} Link to Company News:{002166 CH <Equity> CN <GO>} Link to Company News:{002007 CH <Equity> CN <GO>} Link to Company News:{300009 CH <Equity> CN <GO>}

To contact the editor responsible for this story: Jian Guo Jiang at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.